Linked Life Data

1945464

Source:http://linkedlifedata.com/resource/pubmed/id/1945464

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1991-12-26
pubmed:abstractText
Salmonella-enteritis is known to be an infectious disease of world-wide epidemiologic importance. The treatment of chronic carriers of pathogenic salmonella has shown to be a major therapeutic problem. In a controlled clinical study the efficiency of Hylak forte (containing products of metabolism of symbiotic bacteria) in the management of salmonellosis in infants was investigated. In patients receiving Hylak forte the period of faecal excretion of salmonella was significantly (p = 0.0022) shortened in comparison with the control-group. No side-effects did occur. Hylak forte proved to be effective in the therapy of enteritis in infants; the period of excretion of salmonella was significantly reduced.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0030-9338
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
111-4
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
[Reduction of the duration of salmonella excretion in infants with Hylak forte].
pubmed:affiliation
Klinik für infektiöse Kinderkrankheiten, Medizinischen Akademie Wroclaw, Polen.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Controlled Clinical Trial